This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Kelly Allers: Innovator in Medicinal Chemistry
Introduction
Kelly Allers is a prominent inventor based in Biberach an der Riss, Germany. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative research and development of pharmaceutical compounds. Her work focuses on creating novel therapeutic agents that can address various medical conditions.
Latest Patents
Kelly Allers holds a patent for her invention titled "2-[thiophen-2-yl)formamido]-N-(phenyl)-2-methylpropanamide derivatives and the use thereof as medicament." This patent describes novel compounds that have potential applications in therapy, especially in the treatment or prevention of conditions where the inhibition of the indoleamine 2,3-dioxygenase 1 (IDO1) enzyme may be beneficial. The invention also includes processes for the preparation of these compounds and pharmaceutical compositions containing them.
Career Highlights
Throughout her career, Kelly has been associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her role at the company has allowed her to engage in cutting-edge research and development, contributing to advancements in medicinal chemistry.
Collaborations
Kelly has collaborated with esteemed colleagues, including Stephan Georg Mueller and Klaus Klinder. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic solutions.
Conclusion
In summary, Kelly Allers is a dedicated inventor whose work in medicinal chemistry has led to significant advancements in pharmaceutical development. Her innovative spirit and collaborative efforts continue to drive progress in the field.